StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CSL Limited
ASX:CSL.AX
Sector
Location
Market Cap
USD 76.93 B
Share Price
USD 159.67
Avg Daily Volume
834,388
Change (1 day)
0.26%
Change (1 year)
-20.50%
Change (YTD)
-8.38%
CSL Limited Selling, General, and Administrative Expenses (SG&A) for the year ending June 30, 2024: USD 2.43 B
CSL Limited Selling, General, and Administrative Expenses (SG&A) is USD 2.43 B for the year ending June 30, 2024, a -25.70% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
-
CSL Limited Selling, General, and Administrative Expenses (SG&A) for the year ending June 30, 2023 was USD 3.27 B, a 52.77% change year over year.
-
CSL Limited Selling, General, and Administrative Expenses (SG&A) for the year ending June 30, 2022 was USD 2.14 B, a 31.57% change year over year.
-
CSL Limited Selling, General, and Administrative Expenses (SG&A) for the year ending June 30, 2021 was USD 1.63 B, a 3.83% change year over year.
-
CSL Limited Selling, General, and Administrative Expenses (SG&A) for the year ending June 30, 2020 was USD 1.57 B, a 18.05% change year over year.
Competitors
Illumina, Inc.
USD 100.05
ILMN
+2.61
2.68%
Revvity, Inc.
USD 102.40
RVTY
+2.27
2.27%
Syngene International Limited
USD 7.36
SYNGENE.NS
-0.04
-0.53%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.56
688321.SS
+0.20
4.58%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.19
002317.SZ
+0.01
0.58%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
RELX Plc
USD 54.15
REL.L
+0.69
1.29%
Key Data
| Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
|---|
Competitors
Illumina, Inc.
USD 100.05
ILMN
+2.61
2.68%
Revvity, Inc.
USD 102.40
RVTY
+2.27
2.27%
Syngene International Limited
USD 7.36
SYNGENE.NS
-0.04
-0.53%
Shenzhen Chipscreen Biosciences Co., Ltd.
USD 4.56
688321.SS
+0.20
4.58%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
USD 2.19
002317.SZ
+0.01
0.58%
AbbVie Inc.
USD 195.00
ABBV
+4.38
2.30%
Novo Nordisk A/S
USD 71.29
NOVO-B.CO
+1.87
2.69%
Roche Holding AG
USD 349.07
RO.SW
+1.94
0.56%
Novartis AG
USD 124.22
NOVN.SW
+1.53
1.24%
Abbott Laboratories
USD 133.60
ABT
+0.38
0.29%
AstraZeneca PLC
USD 144.13
AZN.L
+3.37
2.39%
Merck & Co., Inc.
USD 84.02
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 430.73
TMO
+10.85
2.58%
Amgen Inc.
USD 300.37
AMGN
+3.85
1.30%
Boston Scientific Corporation
USD 103.86
BSX
+0.90
0.87%
Pfizer Inc.
USD 25.78
PFE
+0.22
0.86%
Gilead Sciences, Inc.
USD 114.54
GILD
+1.30
1.15%
Vertex Pharmaceuticals Incorporated
USD 479.53
VRTX
+0.56
0.12%
Sanofi
USD 98.46
SAN.PA
+0.82
0.84%
RELX Plc
USD 54.15
REL.L
+0.69
1.29%